INSULIN RESISTANCE TREATMENT You dont have to live with insulin resistance thanks to our diet plans and semaglutide treatments
Astaxanthins antioxidant activity is due to its highly conjugated structure, noted David Padr, Manager of the Nutraceuticals Business of LLS Health
Continued vigilance is essential to support safe administration across heterogeneous cohorts
Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023
This aligns with sustainable weight management strategies that we advocate at our practice
In fact, for many individuals, combining these medications can offer a more robust and comprehensive approach to managing both weight and type 2 diabetes
